Cysteinyl leukotrienes regulate Th2 cell-dependent pulmonary inflammation

Journal of Immunology

Volumn 176, Issue 7, 2006, Pages 4440-4448

  Kim, Daniel C ^a,b   Hsu, F Ida ^a,b   Barrett, Nora A ^a,b   Friend, Daniel S ^a,b   Grenningloh, Roland ^a,b   Ho, I Cheng ^a,b   Al Garawi, Amal ^c   Lora, Jose M ^c   Lam, Bing K ^a,b   Austen, K Frank ^a,b   Kanaoka, Yoshihide ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYTOKINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; LEUKOTRIENE C4 SYNTHASE; MESSENGER RNA; METHACHOLINE; PEPTIDOLEUKOTRIENE; CYSTEINE; CYSTEINYL-LEUKOTRIENE; IMMUNOGLOBULIN; LEUKOTRIENE; OVALBUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL ACTIVATION; CELL HYPERPLASIA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; ENZYME DEFICIENCY; EOSINOPHIL; FEMALE; GOBLET CELL; LYMPH NODE CELL; MAST CELL; MOUSE; MUCUS SECRETION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; SENSITIZATION; SKIN ALLERGY; TH1 CELL; TH2 CELL; ANIMAL; ANTIGEN PRESENTATION; B LYMPHOCYTE; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL DIFFERENTIATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LYMPH NODE; METABOLISM; MOUSE MUTANT; PATHOLOGY;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CELL DIFFERENTIATION; CYSTEINE; CYTOKINES; GENE EXPRESSION REGULATION; IMMUNOGLOBULINS; LEUKOTRIENES; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; OVALBUMIN; PNEUMONIA; RNA, MESSENGER; TH2 CELLS;

EID: 33646036422     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.7.4440     Document Type: Article

References (61)

1. Samuelsson, B., S. E. Dahlen, J. A. Lindgren, C. A. Rouzer, and C. N. Serhan. 1987. Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. Science 237: 1171-1176.
2. 4 that mediates chemotaxis. Nature 387: 620-624.
3. 4 receptor, BLT2: a new therapeutic target in inflammation and immunological disorders. J. Exp. Med. 192: 421-432.
4. 1 receptor. Nature 399: 789-793.
5. Heise, C. E., B. F. O'Dowd, D. J. Figueroa, N. Sawyer, T. Nguyen, D. S. Im, R. Stocco, J. N. Bellefeuille, M. Abramovitz, R. Cheng, et al. 2000. Characterization of the human cysteinyl leukotriene 2 receptor. J. Biol. Chem. 275: 30531-30536.
6. Ford-Hutchinson, A. W., M. A. Bray, M. V. Doig, M. E. Shipley, and M. J. Smith. 1980. Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature 286: 264-265.
7. 4) in human skin. J. Invest. Dermatol. 80: 115-119.
8. Dahlen, S. E., J. Bjork, P. Hedqvist, K. E. Arfors, S. Hammarstrom, J. A. Lindgren, and B. Samuelsson. 1981. Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc. Natl. Acad. Sci. USA 78: 3887-3891.
9. Dahlen, S. E., P. Hedqvist, S. Hammarstrom, and B. Samuelsson. 1980. Leukotrienes are potent constrictors of human bronchi. Nature 288: 484-486.
10. Weiss, J. W., J. M. Drazen, N. Coles, E. R. McFadden, Jr., P. F. Weller, E. J. Corey, R. A. Lewis, and K. F. Austen. 1982. Bronchoconstrictor effects of leukotriene C in humans. Science 216: 196-198.
11. Israel, E., R. Dermarkarian, M. Rosenberg, R. Sperling, G. Taylor, P. Rubin, and J. M. Drazen. 1990. The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N. Engl. J. Med. 323: 1740-1744.
12. 4-receptor antagonist. N. Engl J. Med. 323: 1736-1739.
13. 4 synthase. J. Biol. Chem. 276: 22608-22613.
14. Martin, T. R., N. P. Gerard, S. J. Galli, and J. M. Drazen. 1988. Pulmonary responses to bronchoconstrictor agonists in the mouse. J. Appl. Physiol. 64: 2318-2323.
15. Richter, M., and P. Sirois. 2000. Effects of eicosanoids, neuromediators and bioactive peptides on murine airways. Eur. J. Pharmacol. 389: 225-234.
16. 4 and granulocytic infiltration into asthmatic airways. Lancet 341: 989-990.
17. Pizzichini, E., J. A. Leff, T. F. Reiss, L. Hendeles, L. P. Boulet, L. X. Wei, A. E. Efthimiadis, J. Zhang, and F. E. Hargreave. 1999. Montelukast reduces airway eosinophilic inflammation in asthma: a randomized, controlled trial. Eur. Respir. J. 14: 12-18.
18. Parameswaran, K., H. Liang, A. Fanat, R. Watson, D. P. Snider, and P. M. O'Byrne. 2004. Role for cysteinyl leukotrienes in allergen-induced change in circulating dendritic cell number in asthma. J. Allergy Clin. Immunol. 114: 73-79.
19. Figueroa, D. J., R. M. Breyer, S. K. Defoe, S. Kargman, B. L. Daugherty, K. Waldburger, Q. Liu, M. Clements, Z. Zeng, G. P. O'Neill, et al. 2001. Expression of the cysteinyl leukotriene 1 receptor in normal human lung and peripheral blood leukocytes. Am. J. Respir. Crit. Care Med. 163: 226-233.
20. Figueroa, D. J., L. Borish, D. Baramki, G. Philip, C. P. Austin, and J. F. Evans. 2003. Expression of cysteinyl leukotriene synthetic and signalling proteins in inflammatory cells in active seasonal allergic rhinitis. Clin. Exp. Allergy 33: 1380-1388.
21. Irvin, C. G., Y. P. Tu, J. R. Sheller, and C. D. Funk. 1997. 5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. Am. J. Physiol 272: L1053-L1058.
22. Henderson, W. R., Jr., D. B. Lewis, R. K. Albert, Y. Zhang, W. J. Lamm, G. K. Chiang, F. Jones, P. Eriksen, Y. T. Tien, M. Jonas, and E. Y. Chi. 1996. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J. Exp. Med. 184: 1483-1494.
23. Henderson, W. R., Jr., L. O. Tang, S. J. Chu, S. M. Tsao, G. K. Chiang, F. Jones, M. Jonas, C. Pae, H. Wang, and E. Y. Chi. 2002. A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am. J. Respir. Crit. Care Med. 165: 108-116.
24. 4 receptor 1 in allergen-induced airway hyperresponsiveness. Am. J. Respir. Crit. Care Med. 172: 161-167.
25. 4 receptor 1 confers resistance to airway hyperresponsiveness and Th2-type immune responses. J. Immunol. 175: 4217-4225.
26. Chvatchko, Y., M. H. Kosco-Vilbois, S. Herren, J. Lefort, and J. Y. Bonnefoy. 1996. Germinal center formation and local immunoglobulin E (IgE) production in the lung after an airway antigenic challenge. J. Exp. Med 184: 2353-2360.
27. Williams, C. M., and S. J. Galli. 2000. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J. Exp. Med. 192: 455-462.
28. 4 synthase. Eur. J. Biochem. 248: 807-813.
29. McIntire, J. J., S. E. Umetsu, O. Akbari, M. Potter, V. K. Kuchroo, G. S. Barsh, G. J. Freeman, D. T. Umetsu, and R. H. DeKruyff. 2001. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2: 1109-1116.
30. Friend, D. S., M. F. Gurish, K. F. Austen, J. Hunt, and R. L. Stevens. 2000. Senescent jejunal mast cells and eosinophils in the mouse preferentially translocate to the spleen and draining lymph node, respectively, during the recovery phase of helminth infection. J. Immunol. 165: 344-352.
31. Abonia, J. P., D. S. Friend, W. G. Austen, Jr., F. D. Moore, Jr., M. C. Carroll, R. Chan, J. Afnan, A. Humbles, C. Gerard, P. Knight, et al. 2005. Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle. J. Immunol. 174: 7285-7291.
32. Sheehan, D. C., and B. B. Hrapchak. 1980. Theory and Practice of Histotechnology. Battelle Press, Detroit.
33. Izbicki, G., M. J. Segel, T. G. Christensen, M. W. Conner, and R. Breuer. 2002. Time course of bleomycin-induced lung fibrosis. Int. J. Exp. Pathol. 83: 111-119.
34. Beller, T. C., D. S. Friend, A. Maekawa, B. K. Lam, K. F. Austen, and Y. Kanaoka. 2004. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc. Natl. Acad. Sci. USA 101: 3047-3052.
35. Beller, T. C., A. Maekawa, D. S. Friend, K. F. Austen, and Y. Kanaoka. 2004. Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice. J. Biol. Chem. 279: 46129-46134.
36. Hamada, K., Y. Suzaki, A. Goldman, Y. Y. Ning, C. Goldsmith, A. Palecanda, B. Coull, C. Hubeau, and L. Kobzik. 2003. Allergen-independent maternal transmission of asthma susceptibility. J. Immunol. 170: 1683-1689.
37. Herrick, C. A., H. MacLeod, E. Glusac, R. E. Tigelaar, and K. Bottomly. 2000. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J. Clin. Invest. 105: 765-775.
38. Hamelmann, E., J. Schwarze, K. Takeda, A. Oshiba, G. L. Larsen, C. G. Irvin, and E. W. Gelfand. 1997. Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. Am. J. Respir. Crit. Care Med. 156: 766-775.
39. Ikeda, R. K., M. Miller, J. Nayar, L. Walker, J. Y. Cho, K. McElwain, S. McElwain, E. Raz, and D. H. Broide. 2003. Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol. 171: 4860-4867.
40. Alizadeh, H., J. F. Urban, Jr., I. M. Katona, and F. D. Finkelman. 1986. Cells containing IgE in the intestinal mucosa of mice infected with the nematode parasite Trichinella spiralis are predominantly of a mast cell lineage. J. Immunol. 137: 2555-2560.
41. Urban, J. F., Jr., L. Schopf, S. C. Morris, T. Orekhova, K. B. Madden, C. J. Betts, H. R. Gamble, C. Byrd, D. Donaldson, K. Else, and F. D. Finkelman. 2000. Stat6 signaling promotes protective immunity against Trichinella spiralis through a mast cell- and T cell-dependent mechanism. J. Immunol. 164: 2046-2052.
42. Byrum, R. S., J. L. Goulet, R. J. Griffiths, and B. H. Koller. 1997. Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses. J. Exp. Med. 185: 1065-1075.
43. Schwarze, J., E. Hamelmann, E. W. Gelfand, A. Adler, G. Cieslewicz, and C. G. Irvin. 2005. Barometric whole body plethysmography in mice. J. Appl. Physiol 98: 1955-1957; author reply 1956-1957.
44. Hogan, S. P., K. I. Matthaei, J. M. Young, A. Koskinen, I. G. Young, and P. S. Foster. 1998. A novel T cell-regulated mechanism modulating allergen-induced airways hyperreactivity in BALB/c mice independently of IL-4 and IL-5. J. Immunol. 161: 1501-1509.
45. Corry, D. B., H. G. Folkesson, M. L. Warnock, D. J. Erle, M. A. Matthay, J. P. Wiener-Kronish, and R. M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183: 109-117.
46. Wills-Karp, M., J. Luyimbazi, X. Xu, B. Schofield, T. Y. Neben, C. L. Karp, and D. D. Donaldson. 1998. Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
47. Walter, D. M., J. J. McIntire, G. Berry, A. N. McKenzie, D. D. Donaldson, R. H. DeKruyff, and D. T. Umetsu. 2001. Critical role for 1L-13 in the development of allergen-induced airway hyperreactivity. J. Immunol. 167: 4668-4675.
48. Taube, C., C. Duez, Z. H. Cui, K. Takeda, Y. H. Rha, J. W. Park, A. Balhorn, D. D. Donaldson, A. Dakhama, and E. W. Gelfand. 2002. The role of IL-13 in established allergic airway disease. J. Immunol. 169: 6482-6489.
49. Townsend, J. M., G. P. Fallon, J. D. Matthews, P. Smith, E. H. Jolin, and N. A. McKenzie. 2000. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 13: 573-583.
50. Boyce, J. A., and K. F. Austen. 2005. No audible wheezing: nuggets and conundrums from mouse asthma models. J. Exp. Med. 201: 1869-1873.
51. Mancuso, P., T. J. Standiford, T. Marshall, and M. Peters-Golden. 1998. 5-Lipoxygenase reaction products modulate alveolar macrophage phagocytosis of Klebsiella pneumoniae. Infect. Immun. 66: 5140-5146.
52. 1 receptor-mediated mechanism. J. Pharmacol. Exp. Ther. 281: 655-662.
53. 4 transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103: 757-768.
54. Machida, I., H. Matsuse, Y. Kondo, T. Kawano, S. Saeki, S. Tomari, Y. Obase, C. Fukushima, and S. Kohno. 2004. Cysteinyl leukotrienes regulate dendritic cell functions in a murine model of asthma. J. Immunol. 172: 1833-1838.
55. Okunishi, K., M. Dohi, K. Nakagome, R. Tanaka, and K. Yamamoto. 2004. A novel role of cysteinyl leukotrienes to promote dendritic cell activation in the antigen-induced immune responses in the lung. J. Immunol. 173: 6393-6402.
56. Honig, S. M., S. Fu, X. Mao, A. Yopp, M. D. Gunn, G. J. Randolph, and J. S. Bromberg. 2003. FTY720 stimulates multidrug transporter- and cysteinyl leukotriene-dependent T cell chemotaxis to lymph nodes. J. Clin. Invest. 111: 627-637.
57. Prinz, I., C. Gregoire, H. Mollenkopf, E. Aguado, Y. Wang, M. Malissen, S. H. Kaufmann, and B. Malissen. 2005. The type 1 cysteinyl leukotriene receptor triggers calcium influx and chemotaxis in mouse αβ- and γδ effector T cells. J. Immunol. 175: 713-719.
58. Mellor, E. A., K. F. Austen, and J. A. Boyce. 2002. Cysteinyl leukotrienes and uridine diphosphate induce cytokine generation by human mast cells through an interleukin 4-regulated pathway that is inhibited by leukotriene receptor antagonists. J. Exp. Med. 195: 583-592.
59. 1R. Proc. Natl. Acad. Sci. USA 100: 11589-11593.
60. Eisenbarth, S. C., D. A. Piggott, J. W. Huleatt, I. Visintin, C. A. Herrick, and K. Bottomly. 2002. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J. Exp. Med. 196: 1645-1651.
61. Piggott, D. A., S. C. Eisenbarth, L. Xu, S. L. Constant, J. W. Huleatt, C. A. Herrick, and K. Bottomly. 2005. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J. Clin. Invest. 115: 459-467.